icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
4 Mar, 2021 11:51

EU medicines regulator announces review of data for Russian-made Sputnik V Covid-19 vaccine for potential use by member states

EU medicines regulator announces review of data for Russian-made Sputnik V Covid-19 vaccine for potential use by member states

Better late than never? The European Union has begun an appraisal of the pioneering Sputnik V coronavirus vaccine, developed by Moscow’s Gamaleya Institute, to determine whether the bloc will approve its use for immunizations.

On Thursday, a statement on the European Medicines Agency (EMA) website confirmed that the review had been ordered. According to officials, the “decision to start the rolling review is based on results from laboratory studies and clinical studies in adults.” The move comes after two member states unilaterally approved the jab without waiting for the regulator.

These studies, they add, “indicate that Sputnik V triggers the production of antibodies and immune cells that target the SARS-CoV-2 coronavirus and may help protect against COVID-19.” The EMA will now continue to evaluate data as it becomes available to determine whether “the benefits outweigh the risks.”

The rolling review, the regulator says, is being used “to speed up the assessment of a promising medicine during a public health emergency.” It allows consideration of the jab before all documentation is in place.

Also on rt.com ‘It’s irresponsible to turn vaccines into political issue,’ Hungary’s Orban says of Sputnik V amid EU’s vaccination delay

Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), which financed the development of the formula, said that “We have provided EMA with all the necessary data on the vaccine, which has already been approved by more than 40 countries around the world.”

“Sputnik V has the potential to make a critical contribution to saving millions of lives across Europe,” he said. “Vaccine partnerships must be above politics, and working with the EMA is a great example confirming that only by joining forces can we defeat the pandemic,” he added.

A number of EU member states have already approved the Russian-made jab on an individual basis, without waiting for the central regulator to conduct its review. Sputnik V is already registered in both Hungary and Slovakia.

Hungary’s prime minister, Viktor Orban, told journalists that politics shouldn’t be a factor in making potentially life-saving formulas available. “There is no Eastern or Western vaccine – there are only the good ones and bad ones,” he said. “The Hungarian health authorities have run their tests and guarantee the effectiveness of the vaccine.”

Also on rt.com Slovakia upsets Kiev after PM Matovic jokes that Bratislava swapped Ukraine’s western Transcarpathia for Sputnik V vaccine doses

Think your friends would be interested? Share this story!